We believe that cause-specific disease models are crucial in cardiac drug discovery. Especially heart failure is a heterogenous disease phenotype with different underlying pathophysiology, all leading to the same clinical presentation. River BioMedics has developed different systolic heart failure models based on our 3D Cardiac Strip assay for cause specific target validation and drug discovery.
